{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:20:17Z","timestamp":1771266017490,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T00:00:00Z","timestamp":1323734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00774-011-0341-1","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T06:26:00Z","timestamp":1323671160000},"page":"461-467","source":"Crossref","is-referenced-by-count":10,"title":["Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Giuseppe","family":"Sergi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pintore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Falci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Berton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egle","family":"Perissinotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Monfardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Manzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Coin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"key":"341_CR1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","volume":"359","author":"M Baum","year":"2002","unstructured":"Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T, ATAC Trialists\u2019 Group (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of post-menopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359:2131\u20132139","journal-title":"Lancet"},{"key":"341_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists\u2019 Group (2005) ATAC Trialists\u2019 Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet 365:60\u201362","journal-title":"Lancet"},{"key":"341_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"R Jakesz","year":"2005","unstructured":"Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J, ABCSG and the GABG (2005) On behalf of the ABCSG and the GABG. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2\u00a0years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455\u2013462","journal-title":"Lancet"},{"key":"341_CR4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","volume":"21","author":"R Eastell","year":"2006","unstructured":"Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE, ATAC Trialists\u2019 group (2006) Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial. J Bone Miner Res 21:1215\u20131223","journal-title":"J Bone Miner Res"},{"key":"341_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsbmb.2009.10.004","volume":"118","author":"J Geisler","year":"2010","unstructured":"Geisler J, L\u00f8nnig PE (2010) Impact of aromatase inhibitors on bone health in breast cancer patients. J Steroid Biochem Mol Biol 118:294\u2013299","journal-title":"J Steroid Biochem Mol Biol"},{"key":"341_CR6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","volume":"17","author":"HM Heshmati","year":"2002","unstructured":"Heshmati HM, Khosla S, Robins SP, O\u2019Fallon WM, Melton LJ 3rd, Riggs BL (2002) Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Mineral Res 17:172\u2013178","journal-title":"J Bone Mineral Res"},{"key":"341_CR7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-009-0646-0","volume":"119","author":"FM McCaig","year":"2010","unstructured":"McCaig FM, Renshaw L, Williams L (2010) A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res Treat 119:643\u2013651","journal-title":"Breast Cancer Res Treat"},{"key":"341_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.breast.2008.10.002","volume":"18","author":"O Ortmann","year":"2009","unstructured":"Ortmann O, Cufer T, Dixon JM, Maass N, Marchetti P, Pagani O, Pronzato P, Semiglazov V, Spano JP, Vrdoljak E, Wildiers H (2009) Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast 18:2\u20137","journal-title":"Breast"},{"key":"341_CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3109\/07357907.2010.494321","volume":"28","author":"MT Tirona","year":"2010","unstructured":"Tirona MT, Sehgal R, Ballester O (2010) Prevention of breast cancer (part 1): epidemiology, risk factors, and risk assessment tools. Cancer Invest 28:743\u2013750","journal-title":"Cancer Invest"},{"key":"341_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clon.2008.11.006","volume":"21","author":"GA Thomas","year":"2009","unstructured":"Thomas GA, Leonard RC (2009) How age affects the biology of breast cancer. Clin Oncol 21:81\u201385","journal-title":"Clin Oncol"},{"key":"341_CR11","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/1055-9965.1128.13.7","volume":"13","author":"WF Anderson","year":"2004","unstructured":"Anderson WF, Chu KC, Chang S, Sherman ME (2004) Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13:1128\u20131135","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"341_CR12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.beem.2008.07.002","volume":"22","author":"S Boonen","year":"2008","unstructured":"Boonen S, Dejaeger E, Vanderschueren D, Venken K, Bogaerts A, Verschueren S, Milisen K (2008) Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. Best Pract Res Clin Endocrinol Metab 22:765\u2013785","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"341_CR13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<294::AID-PATH361>3.0.CO;2-Y","volume":"188","author":"JA Hoyland","year":"1999","unstructured":"Hoyland JA, Baris C, Wood L, Baird P, Selby PL, Freemont AJ, Braidman IP (1999) Effect of ovarian steroid deficiency on oestrogen receptor alpha expression in bone. J Pathol 188:294\u2013303","journal-title":"J Pathol"},{"key":"341_CR14","unstructured":"WHO (World Health Organization Technical Report) (1994) Assessment of fracture risk and its applications to screening for menopausal osteoporosis: report of a WHO Study Group. Geneva, Switzerland"},{"key":"341_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejrad.2007.09.040","volume":"69","author":"G Guglielmi","year":"2009","unstructured":"Guglielmi G, Stoppino LP, Placentino MG, D\u2019Errico F, Palmieri F (2009) Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-centre trial. Eur J Radiol 69:173\u2013178","journal-title":"Eur J Radiol"},{"key":"341_CR16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"341_CR17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.clinthera.2007.09.017","volume":"29","author":"MJ V\u00e4lim\u00e4ki","year":"2007","unstructured":"V\u00e4lim\u00e4ki MJ, Farrerons-Minguella J, Halse J, Kr\u00f6ger H, Maroni M, Mulder H, Mu\u00f1oz-Torres M, S\u00e4\u00e4f M, Snorre \u00d8fjord E (2007) Effects of risedronate 5\u00a0mg\/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. Clin Ther 29:1937\u20131949","journal-title":"Clin Ther"},{"key":"341_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"341_CR19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"341_CR20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.2009.24.5902","volume":"28","author":"C Poznak Von","year":"2010","unstructured":"Von Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R (2010) Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE Trial. J Clin Oncol 28:967\u2013975","journal-title":"J Clin Oncol"},{"key":"341_CR21","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/annonc\/mdq217","volume":"21","author":"H Eidtmann","year":"2010","unstructured":"Eidtmann H, de Boer R, Bundred N, Llombart-Cussac A, Davidson N, Neven P, von Minckwitz G, Miller J, Schenk N, Coleman R (2010) Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 21:2188\u20132194","journal-title":"Ann Oncol"},{"key":"341_CR22","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/bcr2565","volume":"12","author":"C Markopoulos","year":"2010","unstructured":"Markopoulos C, Tzoracoleftherakis E, Polychronis A, Venizelos B, Dafni U, Xepapadakis G, Papadiamantis J, Zobolas V, Misitzis J, Kalogerakos K, Sarantopoulou A, Siasos N, Koukouras D, Antonopoulou Z, Lazarou S, Gogas H (2010) Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast Cancer Res 12:R24","journal-title":"Breast Cancer Res"},{"key":"341_CR23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00774-010-0196-x","volume":"29","author":"M Takakuwa","year":"2011","unstructured":"Takakuwa M, Iwamoto J, Konishi M, Zhou Q, Itabashi K (2011) Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study. J Bone Miner Metab 29:88\u201395","journal-title":"J Bone Miner Metab"},{"key":"341_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2011.01.003","volume":"49","author":"M Pazianas","year":"2011","unstructured":"Pazianas M, Abrahamsen B (2011) Safety of bisphosphonates. Bone (NY) 49:103\u2013110","journal-title":"Bone (NY)"},{"key":"341_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10549-009-0432-z","volume":"116","author":"D Mauri","year":"2009","unstructured":"Mauri D, Valachis A, Polyzos IP, Polyzos NP, Kamposioras K, Pesce LL (2009) Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast Cancer Res Treat 116:433\u2013439","journal-title":"Breast Cancer Res Treat"},{"key":"341_CR26","doi-asserted-by":"crossref","unstructured":"Cosman F (2003) Selective estrogen-receptor modulators. Clin Geriatr Med 19:371\u2013379","DOI":"10.1016\/S0749-0690(02)00114-3"},{"key":"341_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2474-12-209","volume":"12","author":"RB Hopkins","year":"2011","unstructured":"Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L (2011) The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord 12:209","journal-title":"BMC Musculoskelet Disord"},{"key":"341_CR28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen A\u00d6, Jacobsen JB, N\u00f8rgaard M, Fryzek JP, S\u00f8rensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999\u20132007). Breast Cancer Res Treat 129:495\u2013503","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-011-0341-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0341-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T18:17:41Z","timestamp":1686507461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-011-0341-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s00774-011-0341-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}